Neuroprotective efficacy of methylene blue in ischemic stroke: an MRI study.
Methylene blue (MB) has unique energy-enhancing and antioxidant properties and is FDA-approved drug to treat methemoglobinemia and cyanide poisoning. This study evaluated the efficacy of MB to treat ischemic stroke in rats using longitudinal MRI and behavioral measures. Rats were subjected to 60-min...
Main Authors: | Qiang Shen, Fang Du, Shiliang Huang, Pavel Rodriguez, Lora Talley Watts, Timothy Q Duong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3836814?pdf=render |
Similar Items
-
The Effects of Methylene Blue on Autophagy and Apoptosis in MRI-Defined Normal Tissue, Ischemic Penumbra and Ischemic Core.
by: Zhao Jiang, et al.
Published: (2015-01-01) -
Stroke Neuroprotection: Targeting Mitochondria
by: Lora Talley Watts, et al.
Published: (2013-04-01) -
Methylene blue treatment in experimental ischemic stroke: A mini-review
by: Zhao Jiang, et al.
Published: (2016-01-01) -
Neuroprotective actions of methylene blue and its derivatives.
by: Ethan Poteet, et al.
Published: (2012-01-01) -
A quantitative MRI method for imaging blood-brain barrier leakage in experimental traumatic brain injury.
by: Wei Li, et al.
Published: (2014-01-01)